Cresset CEO, Dr Robert Scoffin said, "We believe that molecular fields are the most intuitive way of assessing biological activity. We would like every chemist to access the power of fields so that they can truly understand the mechanisms by which their leads interact with targets. torchV10 is such an easy to use desktop tool that it brings these insights within the reach of every medicinal chemist."
Medicinal chemists, research managers, academics and computational chemists who want to find out more about torchV10 can register for a free introductory webinar.
About Cresset
Cresset was formed in 2002 using the basic research of our founder Dr Andy Vinter to introduce a new virtual screening technology. Over the last decade our technology has been widely adopted throughout the drug discovery and agrochemical industries. At the same time our product suite has grown to encompass desktop and enterprise level solutions. Currently our customers include many of the top 20 pharmaceutical companies, large and small biotechs across the USA, Europe and Japan, agrochemical companies as well as top academics.